Drw Securities, LLC Amarin Corp Plcuk Transaction History

Drw Securities, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 14, 2018	SELL	$2.45 - $16.27 $196,980 - $1.31 Million	-80,400 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$2.99 - $4.44 $74,750 - $111,000	25,000 Added 45.13%	80,400 $242,000
Q3 2017 Nov 14, 2017	BUY	$3.03 - $3.72 $167,862 - $206,088	55,400	55,400 $194,000

177

65.1M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $214M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Drw Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Drw Securities, LLC with notifications on news.